![diverse women stacking hands on wooden table](https://u.osu.edu/controvertedissues/files/2022/03/pexels-photo-6457563.jpeg)
Sharing is Caring: Are you ready for the NIH’s Data Management & Sharing Policy? Part 1
![diverse women stacking hands on wooden table](https://u.osu.edu/controvertedissues/files/2022/03/pexels-photo-6457563.jpeg)
Posts about regulatory issues and interpretation
Never fear! In this edition of Five Questions, Quality Improvement Specialist Meliha Rahmani breaks down post-approval monitoring: what it is, why we do it, and what it means for your research.
Earlier this year, the Office of Responsible Research Practices held a two-part webinar series for researchers titled FDA-Regulated Research: Myth vs. Reality – Medical Devices. In this follow-up blog post, we cover where to find session materials and answer questions that we weren’t able to address during the session or that fell outside the scope of the learning objectives.
On September 10, 2020, the Office of Responsible Research Practices held a webinar for researchers titled FDA-Regulated Research: Myth vs. Reality – Part 1: Drugs. In this follow-up blog post, we cover where to find session materials, introduce a “Test your knowledge” exercise, and answer questions that we weren’t able to address during the session or that fell outside the scope of the learning objectives.
Continue reading Re-post: Minding the (db)GaP: Age of Majority and the NIH’s GDS Policy